A carregar...
A New CD10 Antibody Inhibits the Growth of Malignant Mesothelioma
Malignant mesotheliomas (MMs) are aggressive therapy-resistant tumors that generally have a poor prognosis. We previously reported the establishment of four new monoclonal antibodies (mAbs) for the diagnosis and treatment of MM. In this report, we characterized one of these antibodies, JMAM-1. The m...
Na minha lista:
| Publicado no: | Monoclon Antib Immunodiagn Immunother |
|---|---|
| Main Authors: | , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Mary Ann Liebert, Inc., publishers
2021
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7910416/ https://ncbi.nlm.nih.gov/pubmed/33625287 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/mab.2020.0033 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|